Ready to Scale, Ready to Fund - Session 3: Corporate venturing and venture capital deep dive
Ready to Scale, Ready to Fund is a four-session program for founders and teams building medical biotech, medtech and digital health companies. The series brings together practical pitch coaching, go-to-market and IP strategy, venture capital insights, corporate venturing and alternative financing options.
Across the four sessions, participants will strengthen how they present their company, connect scientific or technological innovation to a credible market pathway, and make more informed funding choices. The program is designed around the different development journeys of biotech and healthtech companies, while focusing on the questions investors and strategic partners consistently ask.
Session 3: Corporate venturing and venture capital deep dive
This session provides a practical view of venture capital and corporate venturing for companies with different capital needs, development timelines and partnering models. Participants will examine investor expectations, term sheets, decision timelines and the choices that can shape future financing and strategic freedom.
Program
- Venture capital financing fundamentals
Investor expectations, fundraising stages, process, timelines and preparation. - Term sheets and early-stage VC relationships
Key concepts, negotiation dynamics and how to build a productive investor relationship. - Working with corporate venture teams
How corporates assess opportunities, how CVC differs from financial VC and how to approach strategic investors. - Protecting strategic flexibility
Freedom to operate, exclusivity, rights, future partnering options and alignment with long-term company strategy. - Case discussion and takeaways
Applying the lessons to biotech, medtech and digital health scenarios.
Key topics
- VC expectations, term sheets and timelines
- How to navigate early-stage investor relationships
- How to approach and speak with corporate venturing teams
- How CVC objectives may influence the structure of a deal
- How to manage exclusivity and preserve future financing or partnering options
Ready to join?
The program is open to all Biovia members and HealthTech Investor Summit participants. *Hybrid access is available for participants based outside Belgium.
We encourage you to follow the full series to build progressively from pitch to market strategy and financing.
More info on the other session from the Ready to Scale, Ready to Fund series:
- Session 1: What investors really want to hear (27 October 2026, Online)
- Session 2: Master your go-to-market and IP strategy (05 November 2026, Diegem - Hybrid*)
- Session 4: Funding beyond VCs (26 November 2026, Antwerp - Hybrid*)